REDWOOD CITY, Calif.--(BUSINESS WIRE)--Genelabs Technologies, Inc. (Nasdaq:GNLB), a biopharmaceutical company focused on discovering novel compounds for hepatitis, announced today that Christopher Roberts, Ph.D., Senior Director of Medicinal Chemistry, will present at the Inaugural HCV Drug Discovery conference in La Jolla, California. Dr. Roberts’ presentation titled, “Targeting HCV NS4b Function: A New Approach to Anti-HCV Activity”, will take place on April 29, 2008 at 11:00am.
